OraSure Technologies (NASDAQ:OSUR) has been under a strong bear grip, hence the stock is down -18.54% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 2.56% in the past 1 week. The stock has risen by 3.87% in the past week indicating that the buyers are active at lower levels, but the stock is down -17.22% in the past 4 weeks.
The company shares have rallied 20.37% from its 1 Year high price. On Jun 6, 2016, the shares registered one year high at $7.99 and the one year low was seen on Sep 30, 2015. The 50-Day Moving Average price is $7.05 and the 200 Day Moving Average price is recorded at $6.72.
The stock has recorded a 20-day Moving Average of 4.77% and the 50-Day Moving Average is 8.02%.
OraSure Technologies (NASDAQ:OSUR): stock turned positive on Friday. Though the stock opened at $6.23, the bulls momentum made the stock top out at $6.58 level for the day. The stock recorded a low of $6.21 and closed the trading day at $6.44, in the green by 3.87%. The total traded volume for the day was 991,589. The stock had closed at $6.2 in the previous days trading.
In an insider trading activity,The director officer (COO & CFO) of Orasure Technologies Inc, Spair Ronald H sold 75,974 shares at $10.01 on December 19, 2014. The Insider selling transaction had a total value worth of $760,500. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.